Excalium
← Live feed
Company · News & Financials
Moderna — stock news & what’s moving it
3 recent stories tracked by Excalium
All Moderna news
Moderna/Merck mRNA melanoma vaccine Phase 3 succeeds
Aug 19, 2026 · This success expands the potential market for mRNA technology beyond infectious diseases into oncology, suggesting a sig
Moderna mFLUSIVA flu vaccine approved for adults 50+
Aug 6, 2026 · This FDA approval expands Moderna's product portfolio beyond COVID-19 vaccines, tapping into the lucrative and recurring
FDA advisors unanimously approve Moderna's mRNA vaccine
Jun 21, 2026
Part of the
Excalium
live feed — every business, tech & financial story that might move the stocks you own.